Quarterly report pursuant to Section 13 or 15(d)

Earnings (Loss) Per Common Share (Details)

v3.19.1
Earnings (Loss) Per Common Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Mar. 31, 2019
Mar. 31, 2018
Basic and diluted numerator:        
Net loss attributable to iBio, Inc. stockholders $ (4,223) $ (3,962) $ (13,090) $ (11,687)
Preferred stock dividends 64 64 195 195
Net loss available to iBio, Inc. stockholders $ (4,287) $ (4,026) $ (13,285) $ (11,882)
Basic and diluted denominator:        
Weighted-average common shares outstanding 19,224 11,545 18,597 10,247
Per share amount $ (0.22) $ (0.35) $ (0.71) $ (1.16)